# Optimal Transfusion in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal)

> **NCT01116479** · PHASE2 · TERMINATED · sponsor: **Rigshospitalet, Denmark** · enrollment: 180 (estimated)

## Conditions studied

- Cancer
- Anaemia

## Interventions

- **OTHER:** Blood transfusion

## Key facts

- **NCT ID:** NCT01116479
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 180 (ESTIMATED)
- **Why stopped:** low accrual
- **Last updated:** 2014-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01116479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01116479, "Optimal Transfusion in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01116479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*